References

Abásolo L, Júdez E, MÁ Descalzo, González-Álvaro I, Jover JA, Carmona L Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum. 2008; 37:(6)388-397 https://doi.org/10.1016/j.semarthrit.2007.08.006

Abda E, Selim Z, Teleb S, Zaghira M, Fawzy M, Hamed S. Sexual function in females with rheumatoid arthritis: relationship with physical and psychosocial states. Archives of Rheumatology. 2016; 31:(3)239-247 https://doi.org/10.5606/ArchRheumatol.2016.5838

Al-Herz AA, Saleh K, Al-Awadhi A Characteristics of patients with rheumatoid arthritis in Kuwait: results from the KRRD registry. Annals of the Rheumatic Diseases. 2015; 2 https://doi.org/10.1136/annrheumdis-2015-eular.1739

Aletaha D, Neogi T, Silman AJ 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62:(9)2569-2581 https://doi.org/10.1002/art.27584

Arnett FC, Edworthy SM, Bloch DA The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:(3)315-324 https://doi.org/10.1002/art.1780310302

Aurrecoechea E, Llorca Díaz J, Diez Lizuain ML, McGwin G, Calvo-Alen J. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA. Rheumatol Int. 2017; 37:(4)479-485 https://doi.org/10.1007/s00296-016-3628-7

Azuaga-Pinango AB, Castellanos-Moreira R, Rodriguez-Garcia SC Comorbidities prevalence and charlson index in a cohort of patients with rheumatoid arthritis. Ann Rheum Dis. 2018; 77:(A2) https://doi.org/10.1136/annrheumdis-2018-eular.3216

Balsa A, Lojo-Oliveira L, Alperi-López M Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. Reumatología Clínica. 2019; 15:(2)102-108 https://doi.org/10.1016/j.reumae.2017.06.003

Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380:(9836)37-43 https://doi.org/10.1016/S0140-6736(1012)60240-60242

Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: A systematic review and meta-regression. Psychol Med. 2013; 43:(5)897-910 https://doi.org/810.1017/S003329171200147X

Bombardier C, Hazlewood GS, Akhavan P Canadian Rheumatology Association. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol. 2012; 39:(8)1583-1602 https://doi.org/10.3899/jrheum.120165

Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011; 78:(2)179-183 https://doi.org/10.1016/j.jbspin.2010.07.016

Chandrashekara S, Shobha V, Dharmanand BG Comorbidities and related factors in rheumatoid arthritis patients of south India-Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study. Reumatismo. 2017; 69:(2)47-58 https://doi.org/10.4081/reumatismo.2017.898

Chen H, Manning AK, Dupuis J. A method of moments estimator for random effect multivariate meta-analysis. Biometrics. 2012; 68:(4)1278-1284 https://doi.org/10.1111/j.1541-0420.2012.01761.x

Choi IA, Park SH, Cha HS Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA). Int J Rheum Dis. 2018; 21:(7)1414-1422 https://doi.org/10.1111/1756-185X.13013

Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, Kao CH. Rheumatoid arthritis and risk of acute myocardial infarction—a nationwide retrospective cohort study. Int J Cardiol. 2013; 168:(5)4750-4754 https://doi.org/10.1016/j.ijcard.2013.07.233

Daien C, Hua C, Gaujoux-Viala C Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Joint Bone Spine. 2019; 86:(2)135-150 https://doi.org/10.1016/j.jbspin.2018.10.002

Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011; 66:(3)301-311 https://doi.org/10.1093/gerona/glq208

Vos T, Allen C, Arora M Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388:(10053)1545-1602 https://doi.org/10.1016/S0140-6736(16)31678-6

Dougados M, Soubrier M, Antunez A Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014; 73:(1)62-68 https://doi.org/10.1136/annrheumdis-2013-204223

Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology. 2018; 57:(8)1453-1460 https://doi.org/10.1093/rheumatology/key112

Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis—development over 15 years and evaluation of predictive factors over time. J Rheumatol. 2007; 34:(3)481-487

El-Miedany YM, El Rasheed AHE. Is anxiety a more common disorder than depression in rheumatoid arthritis?. Joint Bone Spine. 2002; 69:(3)300-306 https://doi.org/10.1016/S1297-319X(02)00368-8

Emamifar A, Jensen Hansen IM. The influence of thyroid diseases, diabetes mellitus, primary hyperparathyroidism, vitamin B12 deficiency and other comorbid autoimmune diseases on treatment outcome in patients with rheumatoid arthritis. Medicine (Baltimore). 2018; 97:(21) https://doi.org/10.1097/MD.0000000000010865

Erb N, Pace AV, Douglas KMJ, Banks MJ, Kitas GD. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2004; 33:(5)293-299 https://doi.org/10.1080/03009740410006899

Espiño-Lorenzo P, Manrique-Arija S, Ureña I Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study. Reumatol Clin. 2013a; 9:(1)18-23 https://doi.org/10.1016/j.reuma.2012.05.012

Espiño-Lorenzo P, Manrique-Arija S, Ureña I Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study. Reumatol Clin. 2013b; 9:(1)18-23 https://doi.org/10.1016/j.reuma.2012.05.012

Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, Couderc M, Soubrier M, Dubost JJ. Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum. 2017; 47:(1)129-132 https://doi.org/10.1016/j.semarthrit.2017.01.005

Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, Fortin PR, Menard HA, Donaldson C, Penrod JR. Costs of rheumatoid arthritis: New estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making. 2007; 27:(2)138-150 https://doi.org/110.1177/0272989X06297389

Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003; 423:(6937)356-361 https://doi.org/10.1038/nature01661

Forbes LJ, Marchand C, Doran T, Peckham S. The role of the quality and outcomes framework in the care of long-term conditions: a systematic review. Br J Gen Pract. 2017; 67:(664)e775-e784 https://doi.org/710.3399/bjgp3317X693077

Fu X, Li ZJ, Yang CJ, Feng L, Sun L, Yao Y, Huang YT. The prevalence of depression in rheumatoid arthritis in China: A systematic review. Oncotarget. 2017; 8:(32)53623-53630 https://doi.org/10.18632/oncotarget.17323

Gabriel SE. Why do people with rheumatoid arthritis still die prematurely?. Ann Rheum Dis. 2008; 67:iii30-34 https://doi.org/10.1136/ard.2008.098038

Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999; 26:(11)2475-2479

Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009; 11:(3) https://doi.org/10.1186/ar2669

Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014; 99:(3)923-931 https://doi.org/910.1210/jc.2013-2409

Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018; 21:(3)639-646 https://doi.org/10.1111/1756-185X.13055

Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int. 2014; 34:(9)1275-1280 https://doi.org/10.1007/s00296-014-2972-8

Hansen PR, Feineis M, Abdulla J. Rheumatoid arthritis patients have higher prevalence and burden of asymptomatic coronary artery disease assessed by coronary computed tomography: A systematic literature review and meta-analysis. Eur J Intern Med. 2019; 62:72-79 https://doi.org/10.1016/j.ejim.2019.1002.1018

Hashimoto A, Chiba N, Tsuno H, Komiya A, Furukawa H, Matsui T, Nishino J, Tohma S. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2015; 42:(4)564-571 https://doi.org/10.3899/jrheum.140533

Cochrane Handbook for Systematic Reviews of Interventions, version 6.3 (updated February 2022). 2022. http://www.training.cochrane.org/handbook

Ho CTK, Mok CC, Cheung TT, Kwok KY, Yip RML. Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology. Clin Rheumatol. 2019; 38:(12)3331-3350 https://doi.org/10.1007/s10067-019-04761-5

Ho RCM, Fu EHY, Chua ANC, Cheak AAC, Mak A. Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis. 2011; 14:(1)37-47 https://doi.org/10.1111/j.1756-185X.2010.01591.x

Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012; 65:(9)934-939 https://doi.org/10.1016/j.jclinepi.2011.11.014

Huang CM, Chen HJ, Huang PH, Tsay GJ, Lan JL, Sung FC. Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data. BMJ Open. 2018; 8:(1) https://doi.org/10.1136/bmjopen-2017-018134

Jamshidi AR, Banihashemi AT, Paragomi P, Hasanzadeh M, Barghamdi M, Ghoroghi S. Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population. Rheumatol Int. 2016; 36:(8)1119-1125 https://doi.org/10.1007/s00296-016-3493-4

Jamshidi T, Ghanei Gheshlagh R, Ebtekar F, Dalvand S, Vahedian Azimi A, Kurdi A. Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis. Open Access Rheumatol. 2019; 11:53-59 https://doi.org/10.2147/OARRR.S191459

Jeong H, Baek SY, Kim SW, Eun YH, Kim IY, Kim H, Lee J, Koh EM, Cha HS. Correction: Comorbidities of rheumatoid arthritis: Results from the Korean national health and nutrition examination survey. PLoS One. 2017; 12:(5) https://doi.org/10.1371/journal.pone.0178309

Kaiser R. Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature. Clin Lymphoma Myeloma. 2008; 8:(2)87-93 https://doi.org/10.3816/CLM.2008.n.009

Khan MAB, Hashim MJ, Mustafa H Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020; 12:(7)e9349-e9349 https://doi.org/10.7759/cureus.9349

Kłodziński Ł, Wisłowska M. Comorbidities in rheumatic arthritis. Reumatologia/Rheumatology. 2018; 56:(4)228-233 https://doi.org/10.5114/reum.2018.77974

Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018; 8:(1) https://doi.org/10.1038/s41598-018-21243-x

Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J. 2020; 5:(15)1-6 https://doi.org/10.21037/amj.2020.03.03

Loftus PA, Wise SK. Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg. 2016; 24:(3)245-249 https://doi.org/210.1097/MOO.0000000000000262

Loppenthin K, Esbensen BA, Ostergaard M, Ibsen R, Kjellberg J, Jennum P. Morbidity and mortality in patients with rheumatoid arthritis compared with an age-and sex-matched control population: a nationwide register study. J Comorb. 2019; https://doi.org/10.1177%2F2235042X19853484

Løppenthin K, Esbensen BA, Østergaard M, Ibsen R, Kjellberg J, Jennum P. Morbidity and mortality in patients with rheumatoid arthritis compared with an age-and sex-matched control population: a nationwide register study. J Comorb. 2019; 9

Ma Y, Tong H, Zhang X Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis. Respir Res. 2019; 20:(1) https://doi.org/110.1186/s12931-12019-11123-x

Machin AR, Babatunde O, Haththotuwa R, Scott I, Blagojevic-Bucknall M, Corp N, Chew-Graham CA, Hider SL. The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2020; 39:(5)1471-1482 https://doi.org/10.1007/s10067-019-04900-y

Marques AP, Santo A, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: Literature review update. Rev Bras Reumatol Engl Ed. 2017; 57:(4)356-363 https://doi.org/310.1016/j.rbre.2017.1001.1005

Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013; 52:(12)2136-2148 https://doi.org/10.1093/rheumatology/ket169

Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, Scott DL, Steer S. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014; 44:(2)123-130 https://doi.org/10.1016/j.semarthrit.2014.05.001

Merkesdal S, Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, Mau W, Zeidler H. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. Arthritis Rheum. 2005; 53:(2)234-240 https://doi.org/10.1002/art.21080

Meune C, Touzé E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis. 2010; 103:(4)253-261 https://doi.org/10.1016/j.acvd.2010.03.007

Miao C, Yang Y, He X WNT signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal. 2013; 25:(10)2069-2078 https://doi.org/10.1016/j.cellsig.2013.04.002

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16:(4)223-237 https://doi.org/210.1038/s41581-41019-40244-41582

Misra R, Sharma BL, Gupta R, Pandya S, Agarwal S, Agarwal P, Grover S, Sarma P, Wangjam K. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian Journal of Rheumatology. 2008; 3:(3)S1-S16 https://doi.org/10.1016/S0973-3698(10)60373-1

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339 https://doi.org/10.1136/bmj.b2535

Moll LT, Gormsen L, Pfeiffer-Jensen M. Higher prevalence of depression in patients with rheumatoid arthritis—a systematic review. Ugeskr Laeger. 2011; 173:(41)2564-2568

Naranjo A, Sokka T, Descalzo MA Cardiovascular disease in patients with rheumatoid arthritis: Results from the QUEST-RA study. Arthritis Research and Therapy. 2008; 10:(2) https://doi.org/10.1186/ar2383

National Institute for Health and Care Excellence. Rheumatoid arthritis in adults: Management. NICE guideline [NG100]. 2018. https://www.nice.org.uk/guidance/ng100 (accessed 6 April 2022)

Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology. 2013; 52:(1)99-110 https://doi.org/10.1093/rheumatology/kes262

Page MJ, McKenzie JE, Bossuyt PM The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021; 372 https://doi.org/10.1136/bmj.n1171

Panopoulos S, Tektonidou M, Drosos AA Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther. 2018; 20:(1) https://doi.org/10.1186/s13075-018-1771-0

Panoulas VF, Douglas KMJ, Milionis HJ Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology. 2007; 46:(9)1477-1482 https://doi.org/10.1093/rheumatology/kem169

Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N. The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatology. 2019; 3:(1) https://doi.org/10.1186/s41927-019-0092-5

Przygodzka M, Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Polish Archives of Internal Medicine. 2009; 119:(1-2)39-44 https://doi.org/10.20452/pamw.600

Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, He L. Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin Rheumatol. 2018; 37:(1)179-184 https://doi.org/10.1007/s10067-017-3874-4

R Core Team. R: A language and environment for statistical computing. 2018. https://www.R-project.org/

Rahim RA, Cheng CH. Self-reported symptoms of depression, anxiety and stress among patients with rheumatoid arthritis in a Malaysian rheumatology centre—prevalence and correlates. Med J Malaysia. 2018; 73:(4)226-232 https://doi.org/10.1186/ar2383

Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis & Rheumatism. 2009; 61:(6)794-800 https://doi.org/10.1002/art.24430

Rkain H, Allali F, Jroundi I, Hajjaj-Hassouni N. Socioeconomic impact of rheumatoid arthritis in Morocco. Joint Bone Spine. 2006; 73:(3)278-283 https://doi.org/10.1016/j.jbspin.2005.03.021

Saeedi P, Petersohn I, Salpea P Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from The International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019; 157 https://doi.org/10.1016/j.diabres.2019.107843

Safiri S, Kolahi AA, Hoy D Global, regional and national burden of rheumatoid arthritis 1990–2017: A systematic analysis of the global burden of disease study 2017. Annals of the Rheumatic Diseases. 2019; 78:(11) https://doi.org/10.1136/annrheumdis-2019-215920

Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Diaz C, Anaya JM, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America. Arthritis. 2012; https://doi.org/10.1155/2012/371909

Schau T, Gottwald M, Arbach O, Seifert M, Schopp M, Neus M, Butter C, Zanker M. 2015. Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type. J Rheumatology. 2015; 42:(11)2029-2037 https://doi.org/10.3899/jrheum.141647

Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis: a national clinical guideline. 2011. https://www.nhsggc.org.uk/media/259838/sign-123-management-of-early-rheumatoid-arthritis.pdf (accessed 7 April 2022)

Sheen YH, Rolfes MC, Wi CI, Crowson CS, Pendegraft RS, King KS, Ryu E, Juhn YJ. Association of asthma with rheumatoid arthritis: a population-based case-control study. Journal of Allergy and Clinical Immunology: In Practice. 2018; 6:(1)219-226 https://doi.org/10.1016/j.jaip.2017.06.022

Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis research & therapy. 2015; 17:(1)212-212 https://doi.org/10.1186/s13075-015-0728-9

Smolen JS, Breedveld FC, Burmester GR Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the rheumatic diseases. 2016; 75:(1)3-15 https://doi.org/10.1136/annrheumdis-2015-207524

Staniszewska S, Brett J, Simera I Gripp2 reporting checklists: Tools to improve reporting of patient and public involvement in research. BMJ. 2017; 358 https://doi.org/10.1136/bmj.j3453

Jamovi. Jamovi version 1.0. 2019. http://www.jamovi.org (accessed 21 April 2022)

Thielke SM, Diehr P, Unutzer J. Prevalence, incidence, and persistence of major depressive symptoms in the cardiovascular health study. Aging Ment Health. 2010; 14:(2)168-176 https://doi.org/10.1080/13607860903046537

Wolfe F, Mitchell DM, Sibley JT The mortality of rheumatoid arthritis. Arthritis Rheum. 1994; 37:(4)481-494 https://doi.org/10.1002/art.1780370408

World Health Organization. Depression and other common mental disorders: global health estimates. 2017. http://www.who.int/publications/i/item/depression-global-health-estimates (accessed 7 April 2022)

Yamada T, Nakajima A, Inoue E, Tanaka E, Taniguchi A, Momohara S, Yamanaka H. Incidence of malignancy in japanese patients with rheumatoid arthritis. Rheumatol Int. 2011; 31:(11)1487-1492 https://doi.org/10.1007/s00296-010-1524-0

The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis

02 May 2022
17 min read
Volume 27 · Issue 5

Abstract

This systematic review and meta-analysis estimates the prevalence of common comorbid health disorders in adults with rheumatoid arthritis (RA). A multi-database search strategy was undertaken. Screening, data extraction and quality assessment were carried out by two independent reviewers. A meta-analysis and meta-regression were used to generate a pooled prevalence estimate and identify relevant moderators. After study selection, 33 studies (74633 participants) were included in the meta-analysis. Some 31 studies were judged to be of low risk of bias, and two studies were judged to be at moderate risk of bias. The three most common comorbidities in RA were anxiety disorders (62.1%, 95% Cl: 43.6%; 80.6%), hypertension (37.7%, 95% Cl: 29.2%; 46.2%) and depression (32.1%, 95% Cl: 21.6%; 42.7%). There was substantial statistically significant heterogeneity for all comorbidities (I2 ≥77%). Meta-regression identified that the covariate of mean age (unit increase) had a statistically significant effect on the prevalence of hypertension (+2.3%, 95% Cl: 0.4%; 4.2%), depression (−0.5%, 95% Cl: −0.6%; −0.4%) and cancer (0.5%, 95% Cl: 0.2%; 0.8%) in adults with RA. A country's income was identified to have a statistically significant effect on the prevalence of depression, with low-to moderate-income countries having 40% (95% Cl: 14.0%; 66.6%) higher prevalence than high-income countries. No studies consider health inequalities. It is concluded that comorbidities are prevalent among people with RA, particularly those associated with mental health and circulatory conditions. Provision of health services should reflect the importance of such multimorbidity and the consequences for quality and length of life.

Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease that primarily affects the synovial joints (Miao et al, 2013). It causes inflammation and thickening of the synovium, leading to pain and swelling, which can progress to erosion/damage to the cartilage and bone ends in the joint (Miao et al, 2013). As a progressive disease, it is associated with systemic complications (Firestein, 2003), socioeconomic costs (Merkesdal et al, 2005; Rkain et al, 2006) and consequences in all aspects of an individual's life (Eberhardt et al, 2007; Matcham et al, 2014). Despite improvements in the management of RA, it continues to be associated with increased morbidity, mortality and costs of care (Wolfe et al, 1994; Fautrel et al, 2007; Løppenthin et al, 2019). With more than 24 million people thought to have RA globally (Disease et al, 2016), it represents an often unrecognised challenge to health and social care services (Safiri et al, 2019). Although part of that challenge stems from the condition itself, RA is often accompanied by various comorbidities (additional condition(s) in the presence of a specific index condition of interest) that can affect different body systems (Gabriel, 2008; Espino-Lorenzo et al, 2013a; Jeong et al, 2017; Loppenthin et al, 2019). In addition to the specific effects of the comorbid condition, these may also aggravate the RA, which may cause functional decline, increase the costs of care and the person's risk of death (Gabriel and Michaud, 2009; Norton et al, 2013; Loppenthin et al, 2019).

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month